I Insilico Medicine
Biotechnology company
Updates & Highlights
Drug Target Review · about 11 hours ago
Insilico Medicine launches open-source AI longevity research toolkit
Fortune · about 17 hours ago
Insilico Medicine's Alex Zhavoronkov bets China and AI can deliver the drug industry’s next breakthrough
Unite.AI · 1 day ago
Insilico Medicine Releases Open Longevity AI Toolkit in Cell Study
Recent Openings
View all 3 jobs arrow_forwardMachine Learning Engineer (LLM Architect – Target ID) (UAE)
location_on Remote, GB
All Jobs
Machine Learning Engineer (LLM Architect – Target ID) (UAE)
location_on Remote, GB
Culture & Mission
Benefits & Perks
Health Insurance
Medical, dental & vision
Learning Budget
Professional development
Competitive Salary
Market-rate compensation
Equity/Stock Options
Ownership in the company
Remote Work
Work from anywhere flexibility
Generous PTO
Paid time off
Tech Stack
Core Values
Innovation
Pushing boundaries in AI/ML technology
Collaboration
Working together to achieve more
Excellence
Striving for the highest quality
Impact
Making a difference in the world
Office Locations
Team
Are you on the team at Insilico Medicine?
Claim this company page to verify ownership, edit details, and respond to applicants.
Claim this company arrow_forwardNews & Press
20 recentInsilico Medicine launches open-source AI longevity research toolkit
Insilico Medicine launches open-source AI longevity research toolkit
Drug Target Review · about 11 hours ago
Insilico Medicine's Alex Zhavoronkov bets China and AI can deliver the drug industry’s next breakthrough
Insilico Medicine's Alex Zhavoronkov bets China and AI can deliver the drug industry’s next breakthrough
Fortune · about 17 hours ago
Insilico Medicine Releases Open Longevity AI Toolkit in Cell Study
Insilico Medicine Releases Open Longevity AI Toolkit in Cell Study
Unite.AI · 1 day ago
Insilico Medicine Opens AI Longevity Discovery Toolkit to Researchers Worldwide in Cell Cover Study
Insilico Medicine Opens AI Longevity Discovery Toolkit to Researchers Worldwide in Cell Cover Study
Insilico Medicine · 1 day ago
Insilico Medicine Strengthens Its Middle East Presence with potential Blood Cancer treatment, generated by AI, first of its kind in the UAE
Insilico Medicine Strengthens Its Middle East Presence with potential Blood Cancer treatment, generated by AI, first of its kind in the UAE
Insilico Medicine · 2 days ago
Insilico Medicine launches AI initiative to develop longevity vaccines
Insilico Medicine launches AI initiative to develop longevity vaccines
News-Medical · 3 days ago
Insilico Medicine’s Rentosertib Shows Potential Biological Age Reversal Across Six Proteomic Aging Clocks
Insilico Medicine’s Rentosertib Shows Potential Biological Age Reversal Across Six Proteomic Aging Clocks
Pulse 2.0 · 5 days ago
Across four global innovation hubs: Insilico Medicine executive team to speak at premier healthcare and AI Summits
Across four global innovation hubs: Insilico Medicine executive team to speak at premier healthcare and AI Summits
EurekAlert! · 7 days ago
Cash per share of INSILICO MEDICINE CAYMAN TOPCO – OTC:IMDCY
Cash per share of INSILICO MEDICINE CAYMAN TOPCO – OTC:IMDCY
TradingView · 9 days ago
Insilico Medicine Doses First Patient in GENESIS-IPF-3, the World’s First Phase III Trial of a Generative AI-Driven Innovative Drug
Insilico Medicine Doses First Patient in GENESIS-IPF-3, the World’s First Phase III Trial of a Generative AI-Driven Innovative Drug
Insilico Medicine · 9 days ago
Insilico Medicine Begins Phase III Trial of AI-Discovered Drug Rentosertib for IPF
Insilico Medicine Begins Phase III Trial of AI-Discovered Drug Rentosertib for IPF
The Clinical Trial Vanguard · 9 days ago
Insilico Medicine doses first patient in GENESIS-IPF-3, the first Phase 3 trial of a generative-AI-designed drug
Insilico Medicine doses first patient in GENESIS-IPF-3, the first Phase 3 trial of a generative-AI-designed drug
Dealroom · 9 days ago
Insilico Medicine doses first patient in GENESIS-IPF-3, the world’s first phase III trial of a generative AI-driven innovative drug
Insilico Medicine doses first patient in GENESIS-IPF-3, the world’s first phase III trial of a generative AI-driven innovative drug
EurekAlert! · 9 days ago
Insilico Medicine starts Phase III trial for AI-discovered drug Rentosertib to treat idiopathic pulmonary fibrosis.
Insilico Medicine starts Phase III trial for AI-discovered drug Rentosertib to treat idiopathic pulmonary fibrosis.
Pluang · 9 days ago
Basic earnings per share (basic EPS) of INSILICO MEDICINE CAYMAN TOPCO – OTC:IMDCY
Basic earnings per share (basic EPS) of INSILICO MEDICINE CAYMAN TOPCO – OTC:IMDCY
TradingView · 9 days ago
Hong Kong Stocks Rise on Easing Rate Fears; InSilico Medicine Gains 4%
Hong Kong Stocks Rise on Easing Rate Fears; InSilico Medicine Gains 4%
Moomoo · 15 days ago
Hong Kong Stocks Rise on Easing Rate Fears; InSilico Medicine Gains 4%
Hong Kong Stocks Rise on Easing Rate Fears; InSilico Medicine Gains 4%
marketscreener.com · 15 days ago
Insilico Medicine Cayman Topco's Chairman Initiates Share Increasing Plan
Insilico Medicine Cayman Topco's Chairman Initiates Share Increasing Plan
TradingView · 15 days ago
Insilico Medicine Included in the HKEX Tech 100 Index, Drawing Attention to Opportunities in AI Value Chain
Insilico Medicine Included in the HKEX Tech 100 Index, Drawing Attention to Opportunities in AI Value Chain
The Manila Times · 16 days ago
Insilico Medicine Included in the HKEX Tech 100 Index, Drawing Attention to Opportunities in AI Value Chain
Insilico Medicine Included in the HKEX Tech 100 Index, Drawing Attention to Opportunities in AI Value Chain
Yahoo Finance · 16 days ago